Highlights Klaria Pharma Holding AB

Equities

KLAR

SE0007280326

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 20/06/2024 pm IST			5-day change	1st Jan Change
0.399 ^SEK	+5.00%		+14.33%	-13.64%

16/05	Klaria Pharma Holding AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/02	Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Klaria Pharma Holding AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023	29/02	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02	CI
Klaria Pharma Engages Ernst & Young to Review, Seek Strategic Partnerships	26/02	MT
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	24/11	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/23/25	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Klaria Pharma Faces Regulatory Probe on Inside Information Disclosures Over Rights Issue	28/23/28	MT
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	10/23/10	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2022	10/23/10	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	18/22/18	CI
Klaria Pharma, Pharma Mar to Collaborate on Feasibility Study	07/22/07	MT
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	26/22/26	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2022	12/22/12	CI
Klaria Pharma, FluiMed Partner to Develop Sirolimus Alginate Film to Avoid Organ Transplant Rejection	30/22/30	MT
Klaria Pharmaceuticals Enters into Agreement with FluiMed GmbH to Develop Sirolimus Alginate Film for prevention of Organ Transplant Rejection	30/22/30	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	10/22/10	CI
Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2021	10/22/10	CI
Klaria Pharma AB Initiates Clinical Study with Naloxon Alginate Film	20/21/20	CI
Klaria Pharma Wins Regulatory Nod To Launch Opioid Overdose Treatment Trial In UK	02/21/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Klaria Pharma Holding AB

Equities

KLAR

SE0007280326

Highlights

Filters